查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1417941

語音生物標記市場報告：2030 年趨勢、預測與競爭分析

Speech Biomarker Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 - page report | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

語音生物標記趨勢和預測

預計到 2030 年，全球言語生物標記市場將達到約 14.9 億美元，2024 年至 2030 年CAGR為16.7%。該市場的主要驅動力是言語障礙患病率的增加以及人們對言語生物標記的認知不斷提高。全球言語生物標記市場的未來看起來充滿希望，精神障礙和呼吸衰竭市場存在機會。

依段分類的語音生物標記

該研究包括依類型、應用和區域對全球語音生物標記進行的預測。

語音生物標記市場洞察

Lucintel 預測，由於頻率在評估各種言語障礙方面的利用率不斷提高，因此在預測期內仍將是最大的部分。

在這個市場中，精神障礙仍將是較大的市場區隔。

由於主要製藥公司在該地區的存在，北美在預測期內仍將是最大的地區。

常問問題

Q1. 市場規模：

A1。到 2030 年，全球語音生物標記市場預計將達到 14.9 億美元。

Q2. 市場成長預測：

A2。預計 2024 年至 2030 年，全球語音生物標記市場將以 16.7% 的CAGR成長。

Q3. 影響市場成長的主要推動要素：

A3。該市場的主要驅動力是言語障礙盛行率的增加以及人們對言語生物標記的認知不斷提高。

Q4. 市場的主要部門：

A4。言語生物標記市場的未來看起來充滿希望，精神障礙和呼吸衰竭市場也充滿機會。

Q5. 市場的主要企業：

A5。一些主要的語音生物標記公司如下。

  • Boston Technology
  • Cogito
  • IBM
  • Conversation HEALTH
  • Winterlight Labs

Q6. 預計今後最大的市場部門是：

A6。 Lucintel 預測，由於頻率在評估各種言語障礙方面的利用率不斷提高，因此在預測期內仍將是最大的部分。

Q7.今後5年該市場最大的地區：

A7。由於主要製藥公司在該地區的存在，北美在預測期內仍將是最大的地區。

Q8. 報告客製化的可能性：

A8。是的，Lucintel 提供 10% 的客製化服務，無需任何額外費用。

目錄

第 1 章：執行摘要

第 2 章：全球語音生物標記市場：市場動態

  • 簡介、背景和分類
  • 供應鏈
  • 產業促進因素與課題

第 3 章：2018 年至 2030 年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球語音生物標記市場趨勢（2018-2023）與預測（2024-2030）
  • 依類型分類的全球語音生物標記市場
    • 頻率
    • 振幅
    • 錯誤率
    • 發音時間
  • 全球語音生物標記市場（依應用）
    • 精神障礙
    • 呼吸衰竭
    • 其他

第 4 章：2018 年至 2030 年依地區分類的市場趨勢與預測分析

  • 依地區分類的全球語音生物標記市場
  • 北美語音生物標記市場
    • 北美語音生物標記市場（依應用）：精神障礙、呼吸衰竭等
  • 歐洲語音生物標記市場
    • 歐洲語音生物標記市場（依類型）：頻率、幅度、錯誤率和發音時間
    • 歐洲語音生物標記市場（依應用）：精神障礙、呼吸衰竭等
  • 亞太地區語音生物標記市場
    • 亞太地區語音生物標記市場（依類型）：頻率、幅度、錯誤率和發音時間
    • 亞太地區語音生物標記市場（依應用）：精神障礙、呼吸衰竭等
  • ROW 語音生物標記市場
    • ROW 語音生物標記市場（依類型）：頻率、幅度、錯誤率和發音時間
    • ROW 語音生物標記市場（依應用）：精神障礙、呼吸衰竭等

第 5 章：競爭對手分析

  • 產品組合分析
  • 營運整合
  • 波特五力分析

第 6 章：成長機會與策略分析

  • 成長機會分析
    • 依類型分類的全球語音生物標記市場的成長機會
    • 全球語音生物標記市場的成長機會（依應用）
    • 依地區分類的全球語音生物標記市場的成長機會
  • 全球語音生物標記市場的新興趨勢
  • 戰略分析
    • 新產品開發
    • 全球語音生物標記市場的容量擴張
    • 全球語音生物標記市場的合併、收購和合資企業
    • 認證和許可

第 7 章：領先企業的公司簡介

  • Boston Technology
  • Cogito
  • IBM
  • Conversation HEALTH
  • Winterlight Labs
簡介目錄

Speech Biomarker Trends and Forecast

The future of the global speech biomarker market looks promising with opportunities in the mental disorder and respiratory failure markets. The global speech biomarker market is expected to reach an estimated $1.49 billion by 2030 with a CAGR of 16.7% from 2024 to 2030. The major drivers for this market are increasing prevalence of speech disorders and rising awareness towards speech biomarkers among people.

A more than 150-page report is developed to help in your business decisions.

Speech Biomarker by Segment

The study includes a forecast for the global speech biomarker by type, application, and region.

Speech Biomarker Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Frequency
  • Amplitude
  • Error Rate
  • Pronunciation Time

Speech Biomarker Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Mental Disorder
  • Respiratory Failure
  • Other

Speech Biomarker Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Speech Biomarker Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies speech biomarker companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the speech biomarker companies profiled in this report include-

  • Boston Technology
  • Cogito
  • IBM
  • Conversation HEALTH
  • Winterlight Labs

Speech Biomarker Market Insights

Lucintel forecasts that frequency will remain the largest segment over the forecast period due to its increasing utilization for evaluating various speech disorders.

Within this market, mental disorder will remain the larger segment.

North America will remain the largest region over the forecast period due to presence of major pharmaceutical companies in the region.

Features of the Global Speech Biomarker Market

Market Size Estimates: Speech biomarker market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Speech biomarker market size by type, application, and region in terms of value ($B).

Regional Analysis: Speech biomarker market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the speech biomarker market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the speech biomarker market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the speech biomarker market size?

Answer: The global speech biomarker market is expected to reach an estimated $1.49 billion by 2030.

Q2. What is the growth forecast for speech biomarker market?

Answer: The global speech biomarker market is expected to grow with a CAGR of 16.7% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the speech biomarker market?

Answer: The major drivers for this market are increasing prevalence of speech disorders and rising awareness towards speech biomarkers among people.

Q4. What are the major segments for speech biomarker market?

Answer: The future of the speech biomarker market looks promising with opportunities in the mental disorder and respiratory failure markets.

Q5. Who are the key speech biomarker market companies?

Answer: Some of the key speech biomarker companies are as follows.

  • Boston Technology
  • Cogito
  • IBM
  • Conversation HEALTH
  • Winterlight Labs

Q6. Which speech biomarker market segment will be the largest in future?

Answer: Lucintel forecasts that frequency will remain the largest segment over the forecast period due to its increasing utilization for evaluating various speech disorders.

Q7. In speech biomarker market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to presence of major pharmaceutical companies in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the speech biomarker market by type (frequency, amplitude, error rate, and pronunciation time), application (mental disorder, respiratory failure, and other), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Speech Biomarker Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Speech Biomarker Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Speech Biomarker Market by Type
    • 3.3.1: Frequency
    • 3.3.2: Amplitude
    • 3.3.3: Error Rate
    • 3.3.4: Pronunciation Time
  • 3.4: Global Speech Biomarker Market by Application
    • 3.4.1: Mental Disorder
    • 3.4.2: Respiratory Failure
    • 3.4.3: Other

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Speech Biomarker Market by Region
  • 4.2: North American Speech Biomarker Market
    • 4.2.2: North American Speech Biomarker Market by Application: Mental Disorder, Respiratory Failure, and Other
  • 4.3: European Speech Biomarker Market
    • 4.3.1: European Speech Biomarker Market by Type: Frequency, Amplitude, Error Rate, and Pronunciation Time
    • 4.3.2: European Speech Biomarker Market by Application: Mental Disorder, Respiratory Failure, and Other
  • 4.4: APAC Speech Biomarker Market
    • 4.4.1: APAC Speech Biomarker Market by Type: Frequency, Amplitude, Error Rate, and Pronunciation Time
    • 4.4.2: APAC Speech Biomarker Market by Application: Mental Disorder, Respiratory Failure, and Other
  • 4.5: ROW Speech Biomarker Market
    • 4.5.1: ROW Speech Biomarker Market by Type: Frequency, Amplitude, Error Rate, and Pronunciation Time
    • 4.5.2: ROW Speech Biomarker Market by Application: Mental Disorder, Respiratory Failure, and Other

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Speech Biomarker Market by Type
    • 6.1.2: Growth Opportunities for the Global Speech Biomarker Market by Application
    • 6.1.3: Growth Opportunities for the Global Speech Biomarker Market by Region
  • 6.2: Emerging Trends in the Global Speech Biomarker Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Speech Biomarker Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Speech Biomarker Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Boston Technology
  • 7.2: Cogito
  • 7.3: IBM
  • 7.4: Conversation HEALTH
  • 7.5: Winterlight Labs